Cargando…
Price and affordability of direct-acting antiviral regimens for hepatitis C virus in the United States
Hepatitis C virus is a serious infection causing cirrhosis, liver cancer, and death. The recent development of direct-acting antivirals has dramatically improved tolerability of treatment and rates of cure. However, the high price of these medications has often limited access to care and resulted in...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4867525/ https://www.ncbi.nlm.nih.gov/pubmed/27186235 http://dx.doi.org/10.1186/s13027-016-0071-z |